Provenienza dei contatti di primo grado di Robert Korneluk
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
18
| Subsidiary | Biotechnology | 18 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Korneluk tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
BOMBARDIER INC. | Aerospace & Defense | Corporate Officer/Principal | |
TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Chief Executive Officer Chairman Chief Operating Officer Corporate Officer/Principal | |
HELIX BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
IBEX TECHNOLOGIES | Medical Specialties | Director/Board Member | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
ViOptix, Inc.
ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Medical Specialties | Director/Board Member | |
AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member | |
Cita NeuroPharmaceuticals, Inc.
Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Montréal Exchange, Inc.
Montréal Exchange, Inc. Investment Banks/BrokersFinance Montréal Exchange, Inc. engages in the operation and development of market and clearing services for Canadian and international clients and to commercialize internally developed technology solutions. The Group operates in two segments, namely, Exchange and Clearing House. The Exchange segment acts as the only standardized financial derivatives exchange in Canada, providing a complete range of equity, index and interest rate derivatives. The Clearing House segment acts as clearing house and guarantor for derivative instruments traded at the MX and certain other derivative instruments from the over-the-counter market. The company is headquartered in Montreal, Canada. | Investment Banks/Brokers | Director/Board Member | |
TD Securities, Inc.
TD Securities, Inc. Investment Banks/BrokersFinance TD Securities, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of The Toronto-Dominion Bank (NYSE, TSE: TD). TD Securities provides a wide range of capital market products and services to corporate, government and institutional clients. Their services also include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The firm’s equity group provides research coverage of various sectors. Their fixed-income group provides a full range of underwriting sales and trading products for Canadian, US and European debt issuers and investors. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Bce
Bce Information Technology ServicesTechnology Services BCE is a British company that provides software development services. | Information Technology Services | Corporate Officer/Principal | |
Vaxis Therapeutics Corp
Vaxis Therapeutics Corp Pharmaceuticals: MajorHealth Technology Part of DMK Pharmaceuticals Corp., Vaxis Therapeutics Corp manufactures and researches pharmaceutical products. The company is based in Kingston, Canada. Vaxis Therapeutics was acquired by Cellegy Pharmaceuticals, Inc. on November 29, 2001 for $4 million. | Pharmaceuticals: Major | Chief Executive Officer | |
McGill University | College/University | Masters Business Admin Masters Business Admin Graduate Degree Undergraduate Degree Doctorate Degree | |
Equity Bank (Andover, Kansas)
Equity Bank (Andover, Kansas) Regional BanksFinance Equity Bank, Inc. provides banking services. Its services include personal, online, business banking and other loan services. The company was founded in 1985 and is headquartered in Andover, KS. | Regional Banks | Corporate Officer/Principal | |
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor | |
University of Guelph | College/University | Undergraduate Degree | |
University of Tasmania | College/University | Doctorate Degree | |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor Private Equity Investor | |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Resolution Pharmaceuticals, Inc. | Chief Executive Officer | ||
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Medical Specialties | Director/Board Member | |
Canadian Genetics Diseases Network
Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
AgeChem Financial, Inc.
AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Arab National Bank Investment Co.
Arab National Bank Investment Co. Investment ManagersFinance Arab National Bank Investment Co. (ANB Invest) is wholly-owned subsidiary of Arab National Bank in Saudi Arabia, acting as its sole investment arm. Founded in 2008, the firm is headquartered in Riyadh and offers the full spectrum of investment services both conventional and Shariah-compliant, to all client categories including private & institutional investors. ANB Invest’s asset management division offers a wide range of mutual funds in addition to private portfolios management services in accordance with the various risk appetites and liquidity needs of its individual & institutional clients. | Investment Managers | Chief Executive Officer | |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
gShift Labs, Inc.
gShift Labs, Inc. Packaged SoftwareTechnology Services gShift Labs, Inc. engages in the provision of web presence analytics software. It offers brand development, competitive assessment, digital recruitment, content, influencer, integrated social media, and paid marketing, SEO marketing, web consulting and site audit services. The company was founded in 2009 by Krista LaRiviere and Chris Adams and is headquartered in Barrie, Canada. | Packaged Software | Director/Board Member | |
Remedies Health Care Services, Inc. | Founder | ||
CANNARA BIOTECH INC. | Agricultural Commodities/Milling | Director/Board Member Director of Finance/CFO | |
Ottawa Life Sciences Council | Director/Board Member |
Statistiche
Distribuzione geografica
Canada | 40 |
Stati Uniti | 9 |
Regno Unito | 2 |
Australia | 2 |
Arabia Saudita | 2 |
Settori
Health Technology | 27 |
Finance | 9 |
Consumer Services | 4 |
Commercial Services | 4 |
Electronic Technology | 3 |
Posizioni
Director/Board Member | 149 |
Corporate Officer/Principal | 48 |
Chairman | 26 |
Independent Dir/Board Member | 25 |
Chief Executive Officer | 17 |
Contatti più connessi
Insiders | |
---|---|
Jeremy Curnock-Cook | 60 |
Louis P. Lacasse | 26 |
Donald Olds | 20 |
Michael Berendt | 20 |
Joe Regan | 17 |
Gary Littlejohn | 16 |
Michael B. Cross | 15 |
Lennie Ryer | 12 |
Perry B. Molinoff | 12 |
John W. Gillard | 12 |
James Moodie Rae | 12 |
Inès Holzbaur | 11 |
Serge Langford | 8 |
Mathieu Boudreau | 7 |
Trudie Resch | 2 |
- Borsa valori
- Insiders
- Robert Korneluk
- Connessioni Società